InteRNA Technologies
New Haven
About InteRNA Technologies
InteRNA Technologies secures additional equity financing to progress lead program for melanoma treatment Nijmegen/Utrecht (the Netherlands) – InteRNA Technologies B.V., a biopharma company engaged in the development of microRNA (miRNA)-based therapeutics for oncology, announces today the closing of an equity financing round. New investors participating in this round include the 'Innovation & Investment Fund Gelderland', managed by PPM Oost and several business angels.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $37.9M
- Funding stage: Early Stage Venture
- Last round: Grant (Mar 2021)
- Website: interna-technologies.com
- Phone: 31 24 352 96 33
Industries & Categories
Biotechnology, Information Technology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/interna-technologies-87733 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.